Selective Targeting of Breast Cancer by Tafuramycin A Using SMA-Nanoassemblies

Selective Targeting of Breast Cancer by Tafuramycin A Using SMA-Nanoassemblies

Triple-negative breast cancer (TNBC) is a heterogeneous subtype of tumors that tests negative for estrogen receptors, progesterone receptors, and excess HER2 protein. The mainstay of treatment remains chemotherapy, but the therapeutic outcome remains inadequate. This paper investigates the potential...

Full description

Bibliographic Details
Main Authors: Ibrahim M. El-Deeb, Valeria Pittala, Diab Eltayeb, Khaled Greish
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:Molecules
Subjects:
duocarmycin
tafuramycin A
TNBC
poly(styrene-co-maleic acid) micelles
nanoformulation
EPR effect
Online Access:https://www.mdpi.com/1420-3049/26/12/3532

Similar Items

Similar Items